David E. Morris

High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial

Julian Rosenman, Jan Halle, Mark A. Socinski et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 203 citations

Medicine, Oncology, Radiation Oncology +14

Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I Trial

Mark A. Socinski, David E. Morris, Jan Halle et al. · Journal of Clinical Oncology · 2004 · 153 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Induction Chemotherapy with Carboplatin, Irinotecan, and Paclitaxel Followed by High Dose Three-Dimension Conformal Thoracic Radiotherapy (74 Gy) with Concurrent Carboplatin, Paclitaxel, and Gefitinib in Unresectable Stage IIIA and Stage IIIB Non-small Cell Lung Cancer

Thomas E. Stinchcombe, David E. Morris, Carrie B. Lee et al. · Journal of Thoracic Oncology · 2008 · 78 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Incorporating Bevacizumab and Erlotinib in the Combined-Modality Treatment of Stage III Non–Small-Cell Lung Cancer: Results of a Phase I/II Trial

Mark A. Socinski, Thomas E. Stinchcombe, Dominic T. Moore et al. · Journal of Clinical Oncology · 2012 · 78 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Guidelines for the Initial Management of Metastatic Brain Tumors: Role of Surgery, Radiosurgery, and Radiation Therapy

Matthew G. Ewend, David E. Morris, Lisa A. Carey et al. · Journal of the National Comprehensive Cancer Network · 2008 · 65 citations · Full text

Medicine, Neurosurgery, Surgery +17